NT-proBNP as a Prognostic Factor in Cancer Patients with Septic Shock
Author Information
Author(s): Mokart Djamel, Sannini Antoine, Brun Jean-Paul, Faucher Marion, Blaise Didier, Blache Jean-Louis, Faucher Catherine
Primary Institution: Paoli-Calmette Institute
Hypothesis
Can N-terminal pro-brain natriuretic peptide (NT-proBNP) levels predict ICU mortality in cancer patients with septic shock?
Conclusion
NT-proBNP levels can help identify high-risk cancer patients with septic shock within the first 24 hours of diagnosis.
Supporting Evidence
- The ICU mortality rate was 51%, indicating a significant risk for cancer patients with septic shock.
- NT-proBNP levels were significantly higher in patients with cardiac dysfunction compared to those without.
- An NT-proBNP level above 6,624 pg/ml predicted ICU mortality with high sensitivity and specificity.
Takeaway
Doctors can use a blood test called NT-proBNP to see if cancer patients with a serious infection are likely to survive their hospital stay.
Methodology
A prospective observational study was conducted over one year with 51 cancer patients diagnosed with septic shock.
Limitations
The study had a small sample size and lacked comprehensive hemodynamic data due to reliance on echocardiography.
Participant Demographics
The study included 51 patients, with a median age of 56 years, consisting of 32 men (63%) and 19 women (37%).
Statistical Information
P-Value
0.022
Confidence Interval
1.004 to 1.32
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website